Aspercreme Lidocaine Patch

Manufacturer
Lead Chemical Co. Ltd.
Effective date
2024-01-25
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-06-01 00:08:00

Label at a glance#

ProductAspercreme
Active ingredientLIDOCAINE
Label structure14 sections

Dosage and administration

•   adults and children 12 years of age and older: • clean and dry affected area • remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle • carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area • once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affect...

Label contents#

Full prescribing information#

Active ingredient – Lidocaine Patch US 1ct

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose – Lidocaine Patch US 1ct

OTC - PURPOSE SECTION

Topical anesthetic

Use – Lidocaine Patch US 1ct

INDICATIONS & USAGE SECTION

for the temporary relief of pain

Warnings – Lidocaine Patch US 1ct

WARNINGS SECTION

For external use only

Do not use – Lidocaine Patch US 1ct

OTC - DO NOT USE SECTION

  • on wounds or on irritated or damage skin
  • more than 1 patch on your body at a time or with other topical analgesics at the same time
  • with a heating pad

When using this product – Lidocaine Patch US 1ct

OTC - WHEN USING SECTION

  • use only as directed
  • do not bandage tightly
  • avoid contact with the eyes and mucous membranes
  • do not expose the area to local heat or to direct sunlight

Stop use and ask a doctor if – Lidocaine Patch US 1ct

OTC - STOP USE SECTION

  • condition worsens or symptoms persist for more than 7 days
  • symptoms clear up and occur again within a few days
  • redness is present or excessive skin irritation occurs
  • you experience severe burning pain, swelling, or blistering where the product was applied

If pregnant or breast-feeding, – Lidocaine Patch US 1ct

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children and pets. – Lidocaine Patch US 1ct

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Used patches may still contain the drug product that can produce serious adverse effects if ingested by children or pets. If swallowed, get medical help or contact a Poison Control Center right away.

Directions – Lidocaine Patch US 1ct

DOSAGE & ADMINISTRATION SECTION

•   adults and children 12 years of age and older:

  • clean and dry affected area
  • remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle
  • carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area
  • once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area
  • apply to the affected area not more than 3 to 4 times daily
  • wash hands after applying or removing patch. Throw away the patch after folding sticky ends together.

•   children under 12 years of age: ask a doctor

Inactive ingredients – Lidocaine Patch US 1ct

INACTIVE INGREDIENT SECTION

aluminum glycinate, aluminum hydroxide, cellulose gum, glycerin, methyl acrylate/2-ethylhexyl acrylate copolymer, methylparaben, nonoxynol-30, polyacrylic acid, polysorbate 80, propylene glycol, silica, sodium polyacrylate, tartaric acid, titanium dioxide, urea, water

Active ingredient – Lidocaine Patch Singles US 1ct

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 4%

Purpose – Lidocaine Patch Singles US 1ct

OTC - PURPOSE SECTION

Topical anesthetic

Use – Lidocaine Patch Singles US 1ct

INDICATIONS & USAGE SECTION

For the temporarily relief of pain

Warnings – Lidocaine Patch Singles US 1ct

WARNINGS SECTION

For external use only

Do not use – Lidocaine Patch Singles US 1ct

OTC - DO NOT USE SECTION

  • on puncture wounds, cuts, irritated or swollen skin
  • more than 1 patch on your body at a time or with other topical analgesics at the same time
  • with a heating pad or apply local heat to the area of use

When using this product – Lidocaine Patch Singles US 1ct

OTC - WHEN USING SECTION

  • use only as directed
  • do not bandage tightly
  • avoid contact with the eyes
  • dispose of used patch in manner that always keeps product away from children or pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.

Stop use and ask a doctor if – Lidocaine Patch Singles US 1ct

OTC - STOP USE SECTION

  • condition worsens or symptoms persist for more than 7 days
  • symptoms clear up and occur again within a few days
  • redness or irritation develops
  • you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

If pregnant or breast feeding, – Lidocaine Patch Singles US 1ct

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children and pets. – Lidocaine Patch Singles US 1ct

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions – Lidocaine Patch Singles US 1ct

DOSAGE & ADMINISTRATION SECTION

adults and children over 12 years of age and older:

  • clean and dry affected area
  • remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle
  • carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area
  • once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area
  • use 1 patch at a time and not more than 3 to 4 times daily

children under 12 years of age: consult a doctor

Inactive ingredients – Lidocaine Patch Singles US 1ct

INACTIVE INGREDIENT SECTION

aluminum glycinate, aluminum hydroxide, cellulose gum, glycerin, methyl acrylate/2-ethylhexyl acrylate copolymer, methylparaben, nonoxynol-30, polyacrylic acid, polysorbate 80, propylene glycol, silica, sodium polyacrylate, tartaric acid, titanium dioxide, urea, water

Package/Label Principal Display Panel – Lidocaine Patch US 1ct

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MAX STRENGTH

Aspercreme®with 4% LIDOCAINE
PAIN RELIEF PATCH

NUMBS AWAY PAINFAST ACTING
TARGETS NERVES
FLEXIBLE FABRIC
#1 LIDOCAINE BRAND*

PATCH

FRAGRANCE-FREE
Contains 1 Patch 3-15/16” x 5-1/2” (10 cm x 14 cm)
Pain Relieving Ointment on a Breathable Adhesive Pad

*Among OTC topical analgesics.


Dist. by Chattem, Inc., a Sanofi Company
P.O. Box 2219, Chattanooga, TN
37409-0219 USA
©2022
www.aspercreme.com     Made in Japan

image-01
image-01

Label

Package/Label Principal Display Panel – Lidocaine Patch Singles US 1ct

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MAX STRENGTH

Aspercreme®with 4% LIDOCAINE
PAIN RELIEF PATCH

NUMBS AWAY PAINFAST ACTING
TARGETS NERVES
FLEXIBLE FABRIC
#1 LIDOCAINE BRAND*

PATCH

FRAGRANCE-FREE
Contains 1 Patch 3-15/16” x 5-1/2” (10 cm x 14 cm)
Pain Relieving Ointment on a Breathable Adhesive Pad

*Among OTC topical analgesics


CHATTEM®
A SANOFI COMPANY
Dist. by Chattem, Inc., a Sanofi Company
P.O. Box 2219, Chattanooga, TN
37409-0219 USA ©2020
www.aspercreme.com
Made in Japan

image-02
image-02

Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1737778lidocaine 4 % Medicated PatchPSN8
1737778lidocaine 0.04 MG/MG Medicated PatchSCD8
1737778lidocaine 4 % Medicated PatchSY8

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
070fbed5-7088-434a-a7ce-f2a64d8d40acProduct name220260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80fProduct name520250819
860a93dc-4863-49cc-b284-6bbe8191bc48Product name420250214
eaba870a-6a9d-442e-8643-87b3f558a451Product name120250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86Product name120230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57Product name320210602
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
aed701d5-9c75-dfaf-7154-cde46179faeaProduct name920200313
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
332d03e4-aa24-4b11-841a-02bf41081920Product name120171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
68ed98f8-24c2-44a0-944a-6d36e82ce25aProduct name120141222
1cd42bc2-a430-c72b-636d-991b235fbf80Product name120140508
49fa150c-f0de-cce7-3d9c-993ed81c5698Product name120140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ffProduct name120140508
9137811f-f279-8640-5aeb-99fa2145d64dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62168-0584-4Aspercreme1 in 1 POUCHPATCH18
62168-0584-4Aspercreme400 in 1 CARTONPATCH4008
62168-0584-5Aspercreme400 in 1 CARTONPATCH4008
62168-0584-5Aspercreme1 in 1 POUCHPATCH18
62168-0584-6Aspercreme1 in 1 POUCHPATCH18
62168-0584-6Aspercreme400 in 1 CARTONPATCH4008

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62168-0584ASPERCREME (LIDOCAINE) PATCH [LEAD CHEMICAL CO. LTD.]8Current NDC, Legacy NDC, 6 package rows20240130_275e1343-deef-424a-a883-5e780083af91.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62168-058462168-0584-4, 62168-0584-5, 62168-0584-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AspercremeLIDOCAINELead Chemical Co. Ltd.275e1343-deef-424a-a883-5e780083af912024-01-25WarningsExact identifier
ndc (package): 62168-0584-6
ndc (package): 62168-0584-5
ndc (package): 62168-0584-4
ndc (product): 62168-0584
ndc11 (package): 62168058405
ndc11 (package): 62168058404
ndc11 (package): 62168058406
spl id: 78eddb4d-bd6c-4f22-83fa-a7d68949e1a8
spl set id: 275e1343-deef-424a-a883-5e780083af91

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.